The 21st Century Cures Act established PRGLAC to advise the HHS secretary regarding gaps in knowledge and research on safe and effective therapies for pregnant women and lactating women. PRGLAC was tasked with identifying these gaps and reporting its findings back to the HHS Secretary.
Federal members included the directors of NIH, NICHD, the Centers for Disease Control and Prevention, the HHS Office on Women's Health, and the Commissioner of Food and Drugs, U.S. Food and Drug Administration. Non-federal members included representatives from relevant medical societies, non-profit organizations, and industry.
PRGLAC submitted its recommendations to the HHS secretary in 2019 and completed its work in 2021.
Reports and Recommendations
- PRGLAC Report to the HHS Secretary and Congress, September 2018 (PDF 7 MB)
- List of Recommendations from the PRGLAC Report
- PRGLAC Report Implementation Plan (2020) (PDF 678 KB)
Meetings
- August 21-22, 2017
- November 6-7, 2017
- February 26-27, 2018
- May 14-15, 2018
- May 22, 2019
- August 22-23, 2019
- February 3, 2020
- June 24, 2020
More Information
Contact
Aaron Pawlyk, Obstetric and Pediatric Pharmacology and Therapeutics Branch
Email: pawlykac@mail.nih.gov
BACK TO TOP